文献速递重症综合管理与镇静镇痛心脑血管急症消化、代谢与肾脏急症

生物标志物联合检测在脓毒症心肌损伤早期诊断与预后中的价值

[Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论H-FABP在脓毒症心肌损伤早期诊断和28天预后评估中价值突出,联合NT-proBNP、CK-MB或cTnI可提高诊断与预后判断能力。

该研究纳入2018年10月至2021年1月内蒙古科技大学包头医学院第一附属医院ICU收治的103例脓毒症患者,按入ICU时cTnI≥0.15 μg/L分为脓毒症心肌损伤组(58例)和非心肌损伤组(45例)。结果发现心肌损伤组PCT、CRP、NT-proBNP、CK-MB、cTnI、H-FABP及APACHE II评分均显著高于非心肌损伤组(均P<0.01)。ROC分析显示H-FABP诊断脓毒症心肌损伤的AUC为0.916,优于NT-proBNP(0.756)和CK-MB(0.675);NT-proBNP联合CK-MB及H-FABP诊断的AUC为0.921,敏感度82.1%,特异度88.2%。在28天预后方面,死亡组各指标均显著高于存活组(均P<0.01),H-FABP预测28天死亡的AUC为0.839,优于PCT(0.707)、CRP(0.716)、NT-proBNP(0.761)、CK-MB(0.733)、cTnI(0.824)和APACHE II评分(0.724);NT-proBNP联合cTnI及H-FABP预测不良预后的AUC为0.888,敏感度91.4%,特异度82.6%。

要点

  • 脓毒症心肌损伤诊断标准:入ICU时cTnI≥0.15 μg/L;103例脓毒症患者中心肌损伤58例,非心肌损伤45例。
  • H-FABP诊断脓毒症心肌损伤的AUC为0.916,优于NT-proBNP(AUC=0.756)和CK-MB(AUC=0.675)。
  • NT-proBNP联合CK-MB及H-FABP诊断脓毒症心肌损伤的AUC为0.921,敏感度82.1%,特异度88.2%。
  • H-FABP预测脓毒症心肌损伤患者28天死亡的AUC为0.839,优于PCT、CRP、NT-proBNP、CK-MB、cTnI和APACHE II评分。
  • NT-proBNP联合cTnI及H-FABP预测28天不良预后的AUC为0.888,敏感度91.4%,特异度82.6%。

适用人群与场景

  • 2018年10月至2021年1月内蒙古科技大学包头医学院第一附属医院ICU收治的103例脓毒症患者。

诊断标准与关键阈值

  • 根据入ICU时cTnI水平分组:cTnI≥0.15 μg/L为脓毒症心肌损伤组,cTnI<0.15 μg/L为非脓毒症心肌损伤组。

研究设计与关键结果

  • 研究类型为临床资料分析,纳入103例脓毒症患者,其中心肌损伤组58例、非心肌损伤组45例;心肌损伤组PCT、CRP、NT-proBNP、CK-MB、cTnI、H-FABP及APACHE II评分均显著高于非心肌损伤组(均P<0.01)。
  • Spearman相关分析显示PCT、CRP及APACHE II评分与NT-proBNP、CK-MB、cTnI和H-FABP呈正相关。
  • ROC曲线分析显示H-FABP诊断脓毒症心肌损伤的AUC为0.916,优于NT-proBNP(AUC=0.756)和CK-MB(AUC=0.675);NT-proBNP联合CK-MB及H-FABP诊断的AUC为0.921,敏感度82.1%,特异度88.2%。
  • 脓毒症心肌损伤患者28天存活23例、死亡35例;死亡组血清PCT、CRP、NT-proBNP、CK-MB、cTnI、H-FABP及APACHE II评分均显著高于存活组(均P<0.01)。
  • ROC曲线分析显示H-FABP预测28天死亡的AUC为0.839,优于PCT(AUC=0.707)、CRP(AUC=0.716)、NT-proBNP(AUC=0.761)、CK-MB(AUC=0.733)、cTnI(AUC=0.824)和APACHE II评分(AUC=0.724);NT-proBNP联合cTnI及H-FABP预测不良预后的AUC为0.888,敏感度91.4%,特异度82.6%。

证据类型、等级与局限

  • 证据类型:单中心临床资料分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为H-FABP在脓毒症心肌损伤的早期诊断和预后评估中起重要作用。
  • 作者认为早期联合检测NT-proBNP、CK-MB和H-FABP可显著提高对脓毒症心肌损伤的诊断能力。
  • 作者认为NT-proBNP、cTnI联合H-FABP可显著提高对脓毒症心肌损伤不良预后的预测能力。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury.

METHODS: The clinical data of 103 patients with sepsis admitted to the intensive care unit (ICU) of the First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology from October 2018 to January 2021 were enrolled. According to the cardiac troponin I (cTnI) at admission of ICU, they were divided into septic myocardial injury group (cTnI ≥ 0.15 μg/L) and non-septic myocardial injury group (cTnI < 0.15 μg/L). The serum levels of heart-type fatty acid-binding protein (H-FABP), procalcitonin (PCT), C-reactive protein (CRP), MB isoenzyme of creatine kinase (CK-MB), cTnI and N-terminal pro-brain natriuretic peptide (NT-proBNP) within 6 hours after ICU admission and the worst value of acute physiology and chronic health evaluation II (APACHE II) score within 24 hours after ICU admission in 103 patients was recorded as well as the 28-day prognosis of patient with septic myocardial injury. Spearman correlation analysis was used to analyze the correlation of each index; receiver operating characteristic curve (ROC curve) was drawn, and the area under ROC curve (AUC) was calculated to analyze the early diagnosis and prognostic value of each index and APACHE II score alone or combined detection in patients with septic myocardial injury.

RESULTS: (1) Among 103 patients with sepsis, 58 patients were complicated with myocardial injury and 45 patients were not complicated with myocardial injury. The serum levels of PCT, CRP, NT-proBNP, CK-MB, cTnI, H-FABP and APACHE II score in patients with septic myocardial injury were significantly higher than those in patients without septic myocardial injury [PCT (μg/L): 3.46±1.35 vs. 1.89±0.43, CRP (mg/L): 81.1±26.8 vs. 65.3±19.1, NT-proBNP (U/L): 8 261.4±2 346.9 vs. 6 120.2±1 809.6, CK-MB (U/L): 15.89±6.25 vs. 12.14±4.24, cTnI (μg/L): 1.50 (0.91, 2.21) vs. 0.18 (0.16, 0.19), H-FABP (μg/L): 26.45±8.24 vs. 12.82±5.73, APACHE II score: 24.0 (18.0, 29.0) vs. 16.0 (14.0, 18.0), all P < 0.01]. Spearman correlation analysis showed that PCT, CRP and APACHE II scores were positively correlated with NT-proBNP, CK-MB, cTnI and H-FABP. ROC curve analysis showed that H-FABP in the diagnosis of septic myocardial injury (AUC = 0.916) was superior to NT-proBNP (AUC = 0.756) and CK-MB (AUC = 0.675); the AUC of NT-proBNP and CK-MB combined with H-FABP was 0.921, the sensitivity was 82.1%, and the specificity was 88.2%. (2) Twenty-three patients survived in 28 days, and 35 died. The levels of serum PCT, CRP, NT-proBNP, CK-MB, cTnI, H-FABP and APACHE II score in death group were significantly higher than those in survival group [PCT (μg/L): 3.86±1.27 vs. 2.84±1.24, CRP (mg/L): 92.3 (65.0, 101.7) vs. 74.3 (65.7, 79.8), NT-proBNP (ng/L): 9 106.4±2 013.9 vs. 6 975.5±2 266.7, CK-MB (U/L): 17.90±6.49 vs. 12.82±4.46, cTnI (μg/L): 2.11±0.86 vs. 1.12±0.44, H-FABP (μg/L): 30.08±7.90 vs. 20.93±5.14, APACHE II score: 25.0 (20.0, 30.0) vs. 19.0 (17.0, 24.0), all P < 0.01]. ROC curve analysis showed that H-FABP in evaluating 28-day death of patients with septic myocardial injury (AUC = 0.839) was superior to PCT (AUC = 0.707), CRP (AUC = 0.716), NT-proBNP (AUC = 0.761), CK-MB (AUC = 0.733), cTnI (AUC = 0.824) and APACHE II score (AUC = 0.724); the AUC of NT-proBNP and cTnI combined with H-FABP was 0.888, the sensitivity was 91.4%, and the specificity was 82.6%.

CONCLUSIONS: H-FABP plays an important role in the early diagnosis and prognosis of septic myocardial injury. Early combined detection of NT-proBNP, CK-MB and H-FABP can significantly improve the diagnostic ability of septic myocardial injury, and NT-proBNP and cTnI combined with H-FABP can significantly improve the ability to predict the adverse prognosis of sepsis myocardial injury.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li Z, Cui S, Geng L, et al. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34053488. doi:10.3760/cma.j.cn121430-20210128-00158

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。